A 52-year-old African American male with a long history of poorly controlled hypertension presented to the emergency department (ED) with two days of genital edema and pain. During ED work-up, the patient developed sudden onset of non-pitting, non-pruritic, and non-urticarial upper lip edema. Review of his antihypertensive medication list revealed that he normally took benazepril, highly suggestive of a diagnosis of angiotensin-converting-enzyme inhibitor-related angioedema (ACEI-RA). We present the first reported case of penile ACEI-RA that progressed to involve the oropharynx. The ED management of the condition and some of the newer treatment options available for ACEI-RA is also briefly discussed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703164 | PMC |
| http://dx.doi.org/10.5811/westjem.2015.8.28061 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Refractory Chronic Cough: A State-of-the-Art Review for Otolaryngologists.
Otolaryngol Head Neck Surg
November 2024
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Article Synopsis
- Patients with refractory chronic cough (RCC) are increasingly visiting otolaryngology clinics, requiring better evaluation and management after standard treatments have failed.
- This review highlights new treatment options for RCC, focusing on disrupting the hypersensitive cough reflex through various methods such as neuromodulators, nerve blockades, and behavioral therapies.
- Understanding these emerging strategies is essential for improving treatment outcomes as more patients seek specialized care for RCC in otolaryngology.
Unilateral tongue swelling: an unusual presentation of angiotensin-converting enzyme inhibitor-related angioedema.
BMJ Case Rep
August 2024
Emergency Medicine, Karl Bremer Hospital, Cape Town, Western Cape, South Africa.
Article Synopsis
- * A case report highlights a male in his 60s who experienced unusual swelling of one side of his tongue due to angioedema, emphasizing the need for quick recognition of this condition for effective treatment.
- * This case is noteworthy as it is one of the few documented instances in English literature and the first from Africa, pointing to the possibility of either its rarity or under-reporting in the region, where ACE inhibitors are frequently prescribed.
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.
Int J Clin Oncol
October 2023
Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Article Synopsis
- Cisplatin should be given with diuretics and magnesium while keeping patients hydrated to prevent kidney damage; monitoring kidney function is essential during treatments like pemetrexed, especially for those with low creatinine clearance.
- Mesna helps prevent bladder issues from ifosfamide, and febuxostat can manage high uric acid levels from tumor lysis syndrome; in severe cases, rasburicase is advised.
- Anti-angiogenic drugs may cause protein issues or kidney injuries requiring careful monitoring, dose adjustments, or nephrologist referrals, and acute interstitial nephritis is a common side effect from immune checkpoint inhibitors treated with steroids.
Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study.
Am J Kidney Dis
August 2022
Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Chronic Disease Innovation Centre, Seven Oaks General Hospital, Winnipeg, Manitoba, Canada. Electronic address:
Rationale & Objective: Renin-angiotensin-aldosterone system (RAAS) inhibitors are evidence-based therapies that slow the progression of chronic kidney disease (CKD) but can cause hyperkalemia. We aimed to evaluate the association of discontinuing RAAS inhibitors after an episode of hyperkalemia and clinical outcomes in patients with CKD.
Study Design: Retrospective cohort study.
The First Occurrence of Angioedema After Discontinuation of Angiotensin-Converting Enzyme Inhibitor.
Cureus
November 2021
Internal Medicine, University of Pittsburgh Medical Center McKeesport Hospital, Pittsburgh, USA.
Angioedema is one of the dreaded side effects of angiotensin-converting enzyme (ACE) inhibitors. It has been well established in the literature and the timing of onset is variable from months to years after initiation of therapy. Patients remain at risk of recurrence of angioedema even after discontinuation of the drug if they developed it once while on the drug.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!